Literature DB >> 29746167

A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.

Kelley E McQueeney1, Joseph M Salamoun2, Jennifer G Ahn1, Paula Pekic1, Isabella K Blanco1, Heather L Struckman1, Elizabeth R Sharlow1, Peter Wipf2, John S Lazo1.   

Abstract

Dysregulation of the tightly controlled protein phosphorylation networks that govern cellular behavior causes cancer. The membrane-associated, intracellular protein tyrosine phosphatase PTP4A3 is overexpressed in human colorectal cancer and contributes to cell migration and invasion. To interrogate further the role of PTP4A3 in colorectal cancer cell migration and invasion, we deleted the Ptp4a3 gene from murine colorectal tumor cells. The resulting PTP4A3-/- cells exhibited impaired colony formation, spheroid formation, migration, and adherence compared with the paired PTP4A3fl/fl cells. We replicated these phenotypic changes using the new small-molecule, allosteric PTP4A3 inhibitor JMS-053. A related structure, JMS-038, which lacked phosphatase inhibition, displayed no cellular activity. Reduction in cell viability and colony formation by JMS-053 occurred in both mouse and human colorectal cell lines and required PTP4A3 expression. Ptp4a3 deletion increased the expression of extracellular matrix (ECM) and adhesion genes, including the tumor suppressor Emilin 1. JMS-053 also increased Emilin 1 gene expression. Moreover, The Cancer Genome Atlas genomic database revealed human colorectal tumors with high Ptp4a3 expression had low Emilin 1 expression. These chemical and biologic reagents reveal a previously unknown communication between the intracellular PTP4A3 phosphatase and the ECM and support efforts to pharmacologically target PTP4A3.-McQueeney, K. E., Salamoun, J. M., Ahn J. G., Pekic, P., Blanco, I. K., Struckman, H. L., Sharlow, E. R., Wipf, P., Lazo, J. S. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.

Entities:  

Keywords:  Emilin; extracellular matrix; inhibitor; migration; phosphatase

Mesh:

Substances:

Year:  2018        PMID: 29746167      PMCID: PMC6133700          DOI: 10.1096/fj.201701446R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  58 in total

1.  PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

Authors:  Haihe Wang; Samantha Yiling Quah; Jing Ming Dong; Edward Manser; Jing Ping Tang; Qi Zeng
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

2.  The crucial role of emilin 1 gene expression during progression of tumor growth.

Authors:  Miroslava Rabajdova; Peter Urban; Ivana Spakova; Ladislav Saksun; Rastislav Dudic; Alexander Ostro; Martin Caprnda; Peter Kruzliak; Mariusz Adamek; Maria Marekova
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-31       Impact factor: 4.553

3.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

Review 4.  Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression.

Authors:  Cassandra L Buchheit; Kelsey J Weigel; Zachary T Schafer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

5.  PRL-3/PTP4A3 phosphatase regulates integrin β1 in adhesion structures during migration of human ocular melanoma cells.

Authors:  Malika Foy; Océane Anézo; Simon Saule; Nathalie Planque
Journal:  Exp Cell Res       Date:  2017-03-08       Impact factor: 3.905

6.  PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.

Authors:  Feng Qian; Yu-Pei Li; Xia Sheng; Zi-Chao Zhang; Ran Song; Wei Dong; Shao-Xian Cao; Zi-Chun Hua; Qiang Xu
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

Review 7.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

8.  The polarized distribution of an apical cell surface glycoprotein is maintained by interactions with the cytoskeleton of Madin-Darby canine kidney cells.

Authors:  G K Ojakian; R Schwimmer
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

9.  Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.

Authors:  Zhiying Xu; Hui Chen; Deliang Liu; Jirong Huo
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

10.  The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.

Authors:  Tobias S Slørdahl; Pegah Abdollahi; Esten N Vandsemb; Christoph Rampa; Kristine Misund; Katarzyna A Baranowska; Marita Westhrin; Anders Waage; Torstein B Rø; Magne Børset
Journal:  Oncotarget       Date:  2016-05-10
View more
  6 in total

1.  Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.

Authors:  John S Lazo; Isabella K Blanco; Nikhil R Tasker; Ettore J Rastelli; James C Burnett; Sharon R Garrott; Duncan J Hart; Rebecca L McCloud; Ku-Lung Hsu; Peter Wipf; Elizabeth R Sharlow
Journal:  J Pharmacol Exp Ther       Date:  2019-10-10       Impact factor: 4.030

2.  Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin.

Authors:  Mateusz P Czub; Adam M Boulton; Ettore J Rastelli; Nikhil R Tasker; Taber S Maskrey; Isabella K Blanco; Kelley E McQueeney; John H Bushweller; Wladek Minor; Peter Wipf; Elizabeth R Sharlow; John S Lazo
Journal:  Mol Pharmacol       Date:  2020-09-25       Impact factor: 4.436

3.  Epigenetic adaptations of the masticatory mucosa to periodontal inflammation.

Authors:  Gesa M Richter; Jochen Kruppa; H Gencay Keceli; Emel Tuğba Ataman-Duruel; Christian Graetz; Nicole Pischon; Gunar Wagner; Carsten Rendenbach; Yvonne Jockel-Schneider; Orlando Martins; Corinna Bruckmann; Ingmar Staufenbiel; Andre Franke; Rahime M Nohutcu; Søren Jepsen; Henrik Dommisch; Arne S Schaefer
Journal:  Clin Epigenetics       Date:  2021-11-03       Impact factor: 6.551

4.  Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma.

Authors:  Petros Tsantoulis; Mauro Delorenzi; Ivan Bièche; Sophie Vacher; Pascale Mariani; Nathalie Cassoux; Alexandre Houy; Marc-Henri Stern; Sergio Roman-Roman; Pierre-Yves Dietrich; Arnaud Roth; Wulfran Cacheux
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

5.  Effect of Pharmacological Inhibition of the Catalytic Activity of Phosphatases of Regenerating Liver in Early T Cell Receptor Signaling Dynamics and IL-2 Production.

Authors:  Oscar Aguilar-Sopeña; Sara Hernández-Pérez; Sergio Alegre-Gómez; Patricia Castro-Sánchez; Alba Iglesias-Ceacero; John S Lazo; Pedro Roda-Navarro
Journal:  Int J Mol Sci       Date:  2020-04-05       Impact factor: 5.923

6.  Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.

Authors:  John S Lazo; Elizabeth R Sharlow; Robert Cornelison; Duncan J Hart; Danielle C Llaneza; Anna J Mendelson; Ettore J Rastelli; Nikhil R Tasker; Charles N Landen; Peter Wipf
Journal:  Biomolecules       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.